Skip Navigation



NDT Advance Access published online on January 31, 2006

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfk102
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/6/1534    most recent
gfk102v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chan, R. W.-Y.
Right arrow Articles by Szeto, C.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, R. W.-Y.
Right arrow Articles by Szeto, C.-C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received September 6, 2005
Accepted January 5, 2006


Original Article

The Effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis

Rebecca Wing-Yan Chan 1, Fernand Mac-Moune Lai 2, Edmund Kwok-Ming Li 1, Lai-Shan Tam 1, Kai-Ming Chow 1, Philip Kam-Tao Li 1, and Cheuk-Chun Szeto 1 *

1 Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China
2 Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China

* To whom correspondence should be addressed.
Cheuk-Chun Szeto, E-mail: ccszeto{at}cuhk.edu.hk



  Abstract

Background. Previous studies have shown that messenger RNA (mRNA) expression of target genes is increased in the urinary sediment of patients with active lupus. We study the effect of immunosuppressive therapy on the urinary gene expression profile in patients with active lupus nephritis.

Method. We recruited nine patients with active systemic lupus erythematosus (SLE) and renal disease, and required corticosteroid, with or without cytotoxic treatment. They were followed for 6 months, urine samples were collected at 0, 4, 12 and 24 weeks and gene expression profile was determined by polymerase chain reactions. The pattern of gene expression was compared to clinical parameters of therapeutic response.

Results. Amongst the target genes studied, there was a progressive decline in the urinary expression of T-bet, interleukin (IL)-10, transforming growth factor-beta (TGF-{beta}), monocyte chemoattractant protein-1 (MCP-1), and interferon-gamma (IFN-{gamma}) after immunosuppressive treatment, although the change of IFN-{gamma} was not statistically significant. The time course of their urinary expression was parallel to the systemic activity as reflected by the systemic lupus erythematosus disease activity index (SLEDAI). Throughout the study period, the SLEDAI score correlated significantly with the expressions of IFN-{gamma} (r = 0.43, P = 0.009), T-bet (r = 0.40, P = 0.016), TGF-{beta} (r = 0.51, P = 0.002) and MCP-1 (r = 0.38, P = 0.022). The anti-double strand(anti-ds)DNA antibody titer correlated significantly with the expressions of IFN-{gamma} (r = 0.45, P = 0.009), T-bet (r = 0.37, P = 0.034), IL-10 (r = 0.59, P<0.001), TGF-{beta} (r = 0.44, P = 0.010) and MCP-1 (r = 0.49, P = 0.004). On the other hand, the expression level of IL-2, IL-4, IL-12, IL-18 and GATA-3 remained static throughout the study period.

Conclusions. The mRNA expression of T-bet, IL-10, TGF-{beta}, MCP-1, and probably IFN-{gamma} in the urinary sediment of patients with active lupus nephritis improves with successful immunosuppressive therapy, and the change in gene expression profile is in phase with the clinical disease activity. Measurement of urinary mRNA expression of target genes may be a potential non-invasive tool for the monitoring of lupus disease activity.

Keywords: IL-10; lupus nephritis; SLE; T-bet.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
B. H. Rovin and X. Zhang
Biomarkers for Lupus Nephritis: The Quest Continues
Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1858 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Wang, F. M.-M. Lai, L.-S. Tam, E. K.-M. Li, B. C.-H. Kwan, K.-M. Chow, P. K.-T. Li, and C.-C. Szeto
Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response
Rheumatology, July 1, 2009; 48(7): 755 - 760.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
G. Wang, F. M.-M. Lai, K.-B. Lai, K.-M. Chow, B. C.-H. Kwan, P. K.-T. Li, and C.-C. Szeto
Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
Eur. J. Endocrinol., March 1, 2008; 158(3): 317 - 322.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.